Vena Caval Filter Use in Patients with Sepsis: Results in 175 Patients

Archives of Surgery

Volumn 138, Issue 11, 2003, Pages 1245-1248

  Greenfield, Lazar J ^b   Proctor, Mary C ^a  

^a UNIVERSITY OF MICHIGAN HOSPITALS   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT;

ADOLESCENT; ADULT; AGE; AGED; ANTICOAGULANT THERAPY; ARTICLE; DEVICE REMOVAL; FEMALE; HIGH RISK PATIENT; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROPHYLAXIS; RECURRENT DISEASE; SAFETY; SEPSIS; SEPTICEMIA; SURVIVAL RATE; THROMBOEMBOLISM; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; TREATMENT OUTCOME; VENA CAVA FILTER;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; EMBOLISM; FEMALE; HUMANS; MALE; REGISTRIES; SEPSIS; SURVIVAL ANALYSIS; THROMBOSIS; TREATMENT OUTCOME; VENA CAVA FILTERS;

EID: 0242695753     PISSN: 00040010     EISSN: None     Source Type: Journal    
DOI: 10.1001/archsurg.138.11.1245     Document Type: Article

References (10)

1. Food and Drug Administration Web site. Guidance for Cardiovascular Intravascular Filter 510(K) Submissions. Rockville, Md: Center for Devices and Radiological Help, Interventional Cardiology Devices Branch; 1999. Available at: http: //www.fda.gov/cdrh/ode/24.pdf. Accessed September 5, 2003.
2. Fullen WD, McDonough JJ, Altmeler WA. Clinical experience with vena caval filters. Arch Surg. 1973;106:582-587.
3. Scott JH, Anderson CL, Shankar PS. Septicemia from infected caval "umbrella". JAMA. 1980;243:1133-1134.
4. Peyton JWR, Hylemon MB, Greenfield LJ, Crute S, Sugerman H. Comparison of Greenfield filter and vena caval ligation for experimental septic thromboembolism. Surgery. 1983;93:533-537.
5. Timsit JF, Farkas JC, Boyer JM, et al. Central vein catheter-related thrombosis in intensive care patients: incidence, risk factors, and relationship with catheter related sepsis. Chest. 1998;114:207-213.
6. Esmon CT. Regulation of blood coagulation. Biochim Biophys Acta. 2000;1477: 349-360.
7. Gando S, Nanzaki S, Sasaki S, Aoi K, Kemmotsu O. Activation of the extrinsic coagulation pathway in patients with severe sepsis and septic shock. Crit Care Med. 1998;26:2005-2009.
8. Gando S, Nanzaki S, Morimoto Y, Kobayashi S, Kemmotsu O, Systemic activation of tissue-factor dependent coagulation pathway in evolving acute respiratory distress syndrome in patients with trauma and sepsis. J Trauma. 1999;47: 719-723.
9. McGilvray ID, Rotstein OD. Role of the coagulation system in the local and systemic inflammatory response. World J Surg. 1998;22:179-186.
10. Downing LJ, Strieter RM, Kadell AM, Greenfield LJ, Wakefield TW. Low-dose low-molecular-weight heparin is anti-inflammatory during venous thrombosis. J Vasc Surg. 1998;28:848-854.